ClinicalTrials.Veeva

Menu

3 Snip Punctoplasty With and Without Mitomycine C.

A

Al-Azhar University

Status

Completed

Conditions

Punctal Stenosis

Treatments

Procedure: 3-snip punctoplasty
Procedure: 3-snip punctoplasty and Mitomycin C

Study type

Interventional

Funder types

Other

Identifiers

NCT05586620
3 Snip Punctoplasty

Details and patient eligibility

About

Punctal stenosis is a progressive constriction of the puncta with resultant epiphora. One of the most effective treatment options is 1- to 4-snip punctoplasty combined with or without Mitomycin-C.

Enrollment

18 patients

Sex

All

Ages

16 to 63 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with recurrence of punctal stenosis at the end of 1 month following punctal dilatation.

Exclusion criteria

  • patients with associated lacrimal passage obstruction

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

18 participants in 2 patient groups

3-snip punctoplasty
Active Comparator group
Treatment:
Procedure: 3-snip punctoplasty
3-snip punctoplasty with mitomycin C
Active Comparator group
Treatment:
Procedure: 3-snip punctoplasty and Mitomycin C

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems